The DOI matches its Crossref record; 413 of the 413 references it cites were found in a registry or an index.
Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
Open accessAbstract
Positron emission tomography (PET) uses radioactive tracers and enables the functional imaging of several metabolic processes, blood flow measurements, regional chemical composition, and/or chemical absorption. Depending on the targeted processes within the living organism, different tracers are used for various medical conditions, such as cancer, particular brain pathologies, cardiac events, and bone lesions, where the most commonly used tracers are radiolabeled with 18F (e.g., [18F]-FDG and NA [18F]). Oxygen-15 isotope is mostly involved in blood flow measurements, whereas a wide array of 11C-based compounds have also been developed for neuronal disorders according to the affected neuroreceptors, prostate cancer, and lung carcinomas. In contrast, the single-photon emission computed tomography (SPECT) technique uses gamma-emitting radioisotopes and can be used to diagnose strokes, seizures, bone illnesses, and infections by gauging the blood flow and radio distribution within tissues and organs. The radioisotopes typically used in SPECT imaging are iodine-123, technetium-99m, xenon-133, thallium-201, and indium-111. This systematic review article aims to clarify and disseminate the available scientific literature focused on PET/SPECT radiotracers and to provide an overview of the conducted research within the past decade, with an additional focus on the novel radiopharmaceuticals developed for medical imaging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–413 of 413
Beanlands, R. S., deKemp, R. A., Harmsen, E., Veinot, J. P., Hartman, N., & Ruddy, T. D. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00159-3 · Cited by 12
Fletcher, S. P., Noor, A., Hickey, J. L., McLean, C., White, J. M., & Donnelly, P. S. (2018) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-018-1590-4 · Cited by 12
111In-DANBIRT In Vivo Molecular Imaging of Inflammatory Cells in Atherosclerosis
Mota, R. I., Campen, M. J., Cuellar, M. E., Garver, W. S., Hesterman, J. Y., Qutaish, M. Q., Daniels, T., Nysus, M. V., Wagner, C. R., & Norenberg, J. P. (2018) · Contrast Media & Molecular Imaging · doi:10.1155/2018/6508724 · Cited by 12
Ogawa, K., & Shiba, K. (2018) · Contrast Media & Molecular Imaging · doi:10.1155/2018/4535476 · Cited by 11
Gaonkar, R. H., Wiesmann, F., Pozzo, L. D., McDougall, L., Zanger, S., Mikołajczak, R., Mansi, R., & Fani, M. (2021) · Pharmaceuticals · doi:10.3390/ph14040300 · Cited by 11
Evaluation of quantitative modeling methods in whole-body, dynamic [11C]-erlotinib PET.
Petrulli, J. R., Zheng, M., Huang, Y. H., Nabulsi, N., Goldberg, S. B., Contessa, J. N., & Morris, E. D. (2021) · PubMed Central · Cited by 9
Human Brain Imaging of Opioid Receptors
Ghitza, U. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418677-4.00004-x · Cited by 7
Guehl, N. J., Pelletier‐Galarneau, M., Wooten, D., Guerrero, J., Kas, A., Normandin, M. D., Fakhri, G. E., & Alpert, N. M. (2020) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.119.009407 · Cited by 7
Sakata, M., Toyohara, J., Ishibashi, K., Wagatsuma, K., Ishii, K., Zhang, M.-R., & Ishiwata, K. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.022 · Cited by 6
Treatment response assessment with (R)-[11CPAQ PET in the MMTV-PyMT mouse model of breast cancer
Tegnebratt, T., Lu, L., Eksborg, S., Chireh, A., Damberg, P., Aski, S. N., Foukakis, T., Rundqvist, H., Holmin, S., Kuiper, R., et al. (2018) · EJNMMI Research · doi:10.1186/s13550-018-0380-x · Cited by 6
N-(2-18F-fluoropropionyl)-l-glutamate as a potential oncology tracer for PET imaging of glioma
Sun, A., Liu, S., Tang, X., Pan, Q., Zhang, Z., Ma, H., Nie, D., Tang, C., & Tang, G. (2020) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2020.109530 · Cited by 6
Molecular Targeted Therapy of Lung Cancer
Takiguchi, Y. (2017) · Springer eBooks · doi:10.1007/978-981-10-2002-5 · Cited by 4
Varshney, R. (2020) · Novel Approaches in Cancer Study · doi:10.31031/nacs.2020.05.000611 · Cited by 2
Cited by
Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier
Kamatham, P. T., Shukla, R., Khatri, D. K., & Vora, L. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102481 · Cited by 371
Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation
Dhoundiyal, S., Srivastava, S., Kumar, S., Singh, G., Ashique, S., Pal, R., Mishra, N., & Taghizadeh-Hesary, F. (2024) · European Journal of Medical Research · doi:10.1186/s40001-023-01627-0 · Cited by 144
“…delivery Radiopharmaceutical labeling for tracking gene delivery ‑ Nucleic acid delivery for gene therapy ‑ Targeted gene editing and modulation [73] Personalized medicine Radiotracer‑guided customization of drug delivery ‑ Tailored drug delivery based on patient‑specific Customized treatment…”
BackgroundStrobel, J., Müller, H.-P., Ludolph, A. C., Beer, A. J., Sollmann, N., & Kassubek, J. (2023) · Cells · doi:10.3390/cells12242776 · Cited by 10
Metadata
- Authors
- Crișan, G., Moldovean-Cioroianu, N. S., Timaru, D.-G., Andrieș, G., Căinap, C., & Chiș, V.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-04-30
- Volume
- 23
- Issue
- 9
- Pages
- 5023
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4225247599
- Cited by
- 337
- References
- 413
- FWCI
- 34.37
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.